Find verified Rislenemdaz API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Rislenemdaz for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Rislenemdaz API.
Alternate Names: rislenemdazum, MK-0657, CERC‑301
CAS No: 808733-05-3
PubChem CID: 11394238
Mol Formula: C19H23FN4O2
Mol Weight: 358.4 g/mol
IUPAC Name: (4-methylphenyl)methyl (3S,4R)-3-fluoro-4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate
API Description: Rislenemdaz is an experimental, oral NMDA receptor antagonist that was studied for potential uses in treating major depressive disorder (MDD) and Parkinson's disease. While early phase I trials showed no benefit for Parkinson's disease symptoms, some positive indications for clinical meaningfulness were seen in phase II studies for depression, suggesting a possible role in treating MDD and treatment-resistant depression (TRD).
